Subscribe To
belite bio (blte) stock surges 72% in a month: here's why
belite Bio (BLTE) rises 72% in a month due to encouraging progress on the development of the company's ...
August 21, 2023, 12:47 pm
belite bio, inc (blte) q2 2023 earnings call transcript
belite Bio, Inc (NASDAQ:BLTE ) Q2 2023 Earnings Conference Call August 9, 2023 4:30 PM ET Company Parti...
August 13, 2023, 9:45 am
belite bio doses first subject in pivotal phase 3 phoenix trial evaluating oral tinlarebant for ga
Tinlarebant (a/k/a LBS-008) is belite Bio’s orally administered tablet intended to slow disease progr...
July 27, 2023, 9:00 pm
belite bio completes enrollment in pivotal global phase 3 dragon trial evaluating oral tinlarebant for stargardt disease
Tinlarebant (a/k/a LBS-008) is belite Bio’s orally administered tablet intended to slow disease progr...
July 24, 2023, 10:04 am
Why shares of belite bio soared this week
Investors, seeing the 52-week low, saw a bargain in belite Bio. The company doesn't have any revenue, b...
June 30, 2023, 4:09 pm
belite bio: undercovered eye disease company with early data
BLTE works with retinal disease patients. Their lead asset has positive phase 1 data. Their cash position and trial patient population are two worries...
June 15, 2023, 12:34 pm
Top 5 health care stocks that are set to fly in q2 - clearpoint neuro (nasdaq:clpt), belite bio (nasdaq:blte)
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies....
June 9, 2023, 8:40 am
Why shares of belite bio are slumping wednesday
belite Bio is a clinical-stage biopharmaceutical company focusing on rare eye diseases and other metabo...
May 31, 2023, 12:22 pm
belite bio announces pricing of $30 million underwritten public offering of american depositary shares and warrants
SAN DIEGO, May 30, 2023 (GLOBE NEWSWIRE) — belite Bio, Inc (NASDAQ: BLTE) (“...
May 31, 2023, 12:49 am
belite bio, inc (blte) q1 2023 earnings call transcript
belite Bio, Inc (NASDAQ:BLTE ) Q1 2023 Earnings Conference Call May 11, 2023 8:00 AM ET Company Partici...
May 14, 2023, 4:42 am
belite bio to host webcast on may 11, 2023 to discuss first quarter 2023 financial results
SAN DIEGO, May 10, 2023 (GLOBE NEWSWIRE) -- belite Bio, Inc (NASDAQ: BLTE), a clinical stage biopharmac...
May 10, 2023, 3:33 pm
belite bio, inc (blte) q4 2022 earnings call transcript
belite Bio, Inc (NASDAQ:BLTE ) Q4 2022 Earnings Conference Call April 3, 2023 4:30 PM ET Company Partic...
April 3, 2023, 8:39 pm
belite bio reports full-year 2022 operational highlights and financial results
12-month interim data from the ongoing 2-year, Phase 2 Stargardt disease (STGD1) study continues to show halting or slowing of lesion growth; 18-month...
March 31, 2023, 11:03 pm
belite bio to host webcast on april 3, 2023 to discuss 2022 full year financial results
SAN DIEGO, March 31, 2023 (GLOBE NEWSWIRE) — belite Bio, Inc (NASDAQ: BLTE), a San Diego based clinic...
March 31, 2023, 4:57 pm
belite bio to host webcast on april 3, 2023 to discuss 2022 full year financial results
SAN DIEGO, March 31, 2023 (GLOBE NEWSWIRE) -- belite Bio, Inc (NASDAQ: BLTE), a San Diego based clinica...
March 31, 2023, 12:57 pm